FDA Class II: Fresenius Medical Care Renal Therapies Group, LLC Recalls DELFLEX Peritoneal Dialysis Solution with 4.25% Dextrose, Low Magnesium/ Low Cal
Class II announced by FDA for DELFLEX Peritoneal Dialysis Solution with 4.25% Dextrose, Low Magnesium/ Low Calcium and Attached stay safe Exchange Set. Reason: Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag i...
The U.S. Food and Drug Administration (FDA) has posted an official drug enforcement report concerning Fresenius Medical Care Renal Therapies Group, LLC.
Product and Classification Details
- Recall Number: D-0171-2027
- Classification: Class II
- Recalling Firm: Fresenius Medical Care Renal Therapies Group, LLC
- Status: Ongoing
Reason for Enforcement Action
Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.
Distribution Information
Nationwide in the USA.
Official notification published per FDA Center for Drug Evaluation and Research (CDER) surveillance databases.
This intelligence report was compiled and verified by the NewsKrez Editorial & Regulatory Intelligence Desk in conjunction with openFDA Drug Enforcement & Recalls.
Automated 21 CFR Part 820 & ISO 13485 Verification
Explore Solution →